2011年会议赞助商

RPS

RPS, a next generation CRO, provides comprehensive global Phase 1-4 clinical development solutions to the pharmaceutical, biotechnology and medical device industries. By combining an experienced clinical research operations infrastructure with the industry’s largest resourcing engines, RPS is uniquely positioned to offer our Clients both integrated and full service global outsourcing solutions. These solutions are powered by highly experienced and seasoned study teams providing innovative, cost-effective and high quality services. www.rpsweb.com

Altran

As a worldwide technology leader, we rely on the forces of our network of 17.000 consultants in more than 26 countries, to deliver locally the most innovative and adapted solutions that increase our customers' performance. We are present in China since 1999, with offices in Shanghai & Beijing and presence in Hong-Kong. With more than 1,000 dedicated consultants, Altran Life Sciences delivers the highest level of expertise throughout the global healthcare value chain from R&D of medical products to delivery in the following sectors: pharmaceutical & biotechnology, medical devices and healthcare. Our offers are adapted to the local Life Sciences companies' specifics allowing compliance and efficiency.

PAREXEL

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 52 countries around the world, and has approximately 10,380 employees. For more information about PAREXEL International visit www.PAREXEL.com

PPD

PPD is a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 44 countries and more than 11,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit www.ppdi.com.

PhamaNet/i3
PharmaNet/i3, the inVentiv Health clinical segment, is recognized as a leading provider of global drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies, including therapeutically specialized capabilities for Phase I-IV clinical development, bioanalytical services, and staffing from a single clinical professional to an entire functional team. For intelligent solutions needed to accelerate high quality drug development programs of all sizes around the world, PharmaNet/i3 works for you. For more information, visit http://www.pharmanet-i3.com.

Quintiles

Quintiles is the only fully integrated biopharmaceutical services provider offering clinical, commercial consulting and capital solutions worldwide. We help customers manage change, navigate risk and seize opportunities in the new health landscape. Quintiles’ more than 20,000 talented, engaged employees in nearly 60 countries deliver on promises to customers every day, working with an unwavering commitment to patients, safety and ethics. As a pioneer in biopharmaceutical services, Quintiles has helped develop or commercialize all of the top 30 best-selling drugs. Quintiles is consistently cited as the most favored contract research organization (CRO) in independent surveys of the biopharma industry. www.quintiles.com

Adicon

Shanghai Adicon Clinical Laboratory, a leading full-service central lab for clinical trials in China, conducts activities to support new pharmaceutical developments including clinical trials and CRO (contract research organization) business.

adicon is accordance with ICH GCP and is qualified with CAP, CMA and NGSP level 1. It's sample collection sites cover China mainland, Taiwan, Hong Kong and Japan, etc. Adicon also offers many types of service, including Central lab testing, ambient and cold chain logistics, project management and sample management services.

For more information about Adicon, pls visit www.adicon.com.cn

Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry®, is the largest REIT focused principally on providing high-quality real estate for the life science industry. Since 1994, Alexandria has created first-in-class life science clusters that foster innovative and collaborative environments in key locations immediately proximate to leading research institutions. Alexandria’s broad and diverse tenant base includes internationally renowned academic and medical institutions, multinational pharmaceutical companies, leading private and public biotechnology entities, non-profit institutions, government agencies, medical device companies, biofuels companies, research tools and service companies, and venture capitalists. Located in the top life science markets around the globe, Alexandria’s world-class properties, highly specialized operations, and expansive network assist the life science industry in translating promising discoveries into important, safe, and effective products that benefit humankind.

Aperio

Aperio is improving patient care through digital pathology with a rapidly growing global installed base of more than 750 systems in over 30 countries, including nearly 500 systems in hospitals and references labs, the 13 largest pharmaceutical companies and a multitude of biotechnology and government organizations. As digital pathology moves closer to the critical path among clinical organizations, hospitals and academic medical centers are using Aperio’s systems to improve secondary and intra-operative consultations, tumor boards and quality assurance over reads.

Our comprehensive product line features ScanScope® scanners, Spectrum™ image management (PACS) software, SecondSlide® consultation network for pathology, and image analysis tools. www.aperio.com

Athena Healthcare Consultancy

Since 2005, Athena Healthcare Consultancy, with its headquarters in Shanghai, continues to provide innovative clinical research services in China. Trusted by hundreds of biopharmaceutical companies, CRO’s, academic - and government organizations worldwide, the OpenClinica® Enterprise software and support services are now available by ATHENA – AKAZA RESEARCH to further optimize electronic data capture and data management, increasing the speed of collection and quality of data in clinical trials in China. OpenClinica® Enterprise (English and Chinese versions) meets HIPAA, 21 CFR Part 11 and other regulatory requirements and is designed as a standards-based, extensible, and modular platform. For more information see www.openclinica.cn.

BBK Worldwide

Founded in 1983, BBK Worldwide, the internationally recognized leader in patient recruitment programs and services, delivers innovative solutions to achieve predictable results in clinical trial enrollment. BBK has successfully supported thousands of clinical studies, from Phase I through IV and other late phase trials, in all major therapeutic areas. With BBK, the priorities of the scientific research are seamlessly combined with a marketing perspective. This is arrived at through strict adherence to research and analytic methodologies created and perfected by BBK during its long history of service to the clinical trial industry. www.bbkworldwide.com

Boon

Boon Pharmaceutical Research is a Biometrics solutions provider.
Systems: All Boon systems are being audited to be in compliance with the FDA’s 21CFR11.

• Boon® CDMS: > 50 clinical trials since 2002 with many databases being submitted to the FDA and EMA
• Boon® EDC: 4 clinical trials in China and 2 in the US; Joint projects with Fuwai Hospital and PUMCH
• Boon® IWRS: used as a standalone or with Boon® EDC as an introductory phase to the system

• ADS, TLG, ISS programming and CDISC conversion; > 35 projects

• Protocol development, CRF design, SAP and TLG mock-ups; > 50 projects

c3i

C3i is the leading provider of end-to-end technology services for sponsors and CROs running global clinical trials. C3i's portfolio of business process outsourcing services for EDC, IVRS/ IRT, CTMS, and ePRO applications includes: 24x7 multi-lingual contact center, systems integration, technology training, asset management, provisioning, technical site assessments, and applicaton hosting exclusively tailored for the needs of clinical professionals.

C3i works with 9 of the top 10 pharmaceutical companies and supports over 250,000 clinical end users. C3i is headquartered in the United States and has integrated global operations centers in the United States, Europe, India and China. For more information visit www.c3i-inc.com.

Covance

Eliving

Eliving is a full-service clinical contract research organization (CRO) with more than 230 employees in China, providing time-saving expertise and trial management for clinical and regulatory needs. Eliving headquarters in Shenyang where our central labs are located. The Beijing and Shanghai branches are the operational centers, managing clinical researches across the country. The unique management of sites, extensive network with hospitals and unparalleled insight to Chinese regulatory affairs are the foundations for Eliving’s constant successes. Since 2001, more than 400 projects have been completed by Eliving for over 100 clients, with reduced timelines and enhanced productivity and quality. While Eliving is among the fastest growing CROs, the company goal is to become the most preferred CRO doing clinical trials in China. http://eliving-pharm.com.

elsevier

Elsevier Science & Technology Books is pleased to be at the forefront of publishing for the clinical trials market. The new Elsevier books; Global Clinical Trials Effective Implementation and Management and the Global Clinical Trials Playbook: Management and Implementation when Resources are Limited are written by industry experts and China Trials speakers; Menghis Bairu and Richard Chin. These books and others from Elsevier explore the great opportunities and challenges that exist when conducting clinical trials in established or emerging markets. Visit us and find out more today. Information can be found at info.sciverse.com/books or browse our collection at elsevierdirect.com.

Fountain Medical Development

Fountain Medical Development Corp. is a contract research organization (CRO) offering a full range of ICH GCP compliant clinical research services for multinational clients conducting clinical research in China. The management team of Fountain has decades of combined experience working with the world's leading CRO's and drug developers. In the Chinese CRO market, we fill the void of a service provider that balances high quality with moderate cost. Our extensive global experience in multiple therapeutic areas is unmatched by other local CRO's, and our lower operational cost allows us to pass significant savings on to our clients. In addition to the founders, we have assembled the highest quality team that is capable of handing regulatory affairs, clinical operations, safety, project management, data management and statistical analysis. Furthermore, through our internal team and a global network of consultants, we are one of the only local CRO’s capable of global standard clinical trial protocol design. www.fountain-med.com.

GCP ClinPlus

GCP ClinPlus Co., Ltd. provides clinical research solutions which are customized and comprehensive, of international standards and making full use of various network and resources. The services of GCP ClinPlus, with the untiring effort of innovation and extending to new field, cover the evaluation and counseling of new drug R&D, regulatory affairs, clinical trial monitoring and management, data management, statistical analysis, medical affair and training, involving fields of pharmaceutical, biological product and medical device.

In early 2011, GCP signed the JV agreement with CMIC Co., Ltd. to enhance the capability and widen the geographic coverage. The win-win cooperation would surely enhance the core competitiveness and open a new chapter of accelerating development of GCP Clinplus Co., Ltd. www.gcp-clinplus.com

George Clinical

George Clinical is the contract research division of The George Institute, which manages phase II to phase IV clinical studies for commercial entities and for medical research organizations. George Clinical is recognized as a world class Academic Research Organisation. We couple the medical and scientific expertise of The George Institute with operational excellence and a broad Asia Pacific presence.

George Clinical offers all the essential elements required to conduct high-quality clinical research with experience in both registration and post-registration studies for a range of sponsors. Services include protocol development, clinical & medical monitoring, project management, data management, statistical services, endpoint management and committee management. www.georgeclinical.com

GleneaglesCRC

GleneaglesCRC is the Regional CRO in Asia. A Joint Venture between ParkwayHealth (Singapore) & Mitsui & Co (Japan), we have leading operations in Singapore, Thailand, Malaysia, China, Philippines, Indonesia, Australia, South Korea, India and Vietnam, providing global & regional BioPharma customers with full service clinical research & outsourcing solutions. With its Asian heritage, GleneaglesCRC offers significant experience across the region and has a flexible delivery model linked to an unparalleled network of sites and investigators. www.gleneaglescrc.com

ICON

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies.

With headquarters in Dublin, Ireland, ICON currently operates from 77 locations in 39 countries and has approximately 7,800 employees. Over 1,000 of these employees are based in 14 different countries throughout Asia Pacific. ICON Clinical Research specialises in the planning management, execution and analysis of Phase IIb – IV clinical trials, ranging from small studies to complex, multinational projects. www.iconplc.com

Kingmed

KingMed comprehensive and cost effective laboratory solutions to leading pharmaceutical and biotech companies. Through its 19 primary testing centers located in Guangzhou, Shanghai, Hongkong and other provincial capital cities in mainland China and equipped with its remarkable degree of advanced technology and research and development capabilities, we now are able to provide Central Lab, Esoteric Tests, Logistics and Sample Management Services. www.kingmed.com.cn

MicroConstants

As a pharmacokinetics specialty CRO in China, MicroConstants China’s mission is to conduct preclinical and clinical studies according to China SFDA, USFDA, and OECD guidelines. Our “Integrated Early Stage Clinical Trial Services” includes protocol & CRF development, clinical site qualification, subject recruitment, clinical trial monitoring, clinical sample bioanalysis, data management, data analysis and clinical report. Our in- house bioanalytical lab received endorsement of OECD GLP compliance in 2011. www.microconstants.com

Oracle

Oracle is a leading strategic software solutions provider to the health sciences industry, helping pharmaceutical, biotechnology, medical device, and healthcare organizations become the most successful in the world by offering the most innovative products and services that deliver the most compelling customer and shareholder value. Oracle's comprehensive industry solutions include clinical trial management and analysis, electronic data capture, adverse event reporting and pharmacovigilance, and healthcare interoperability. Oracle partners with health sciences industry leaders – including 20 of the top 20 life sciences companies and 14 of the top 14 Fortune Global 500 healthcare organizations – to prevent and cure disease, enhance quality of life, and accelerate insights for better health. www.oracle.com

Proswell Medical Company

Proswell Medical Company is one of the largest CRO companies in China. Founded in 2004, Proswell has been well experienced in protocol design and project management for over 7 years. We are the first CRO company certified by ISO 9001 in China. We possess a professional team with high quality and out-standing executive enforcement.

Proswell’s business covers the services of Phases I-IV clinical trials and data management, subject recruiting, clinical mornitoring and auditing. We have great advantages to serve in the areas of oncology, cardio-angiology, psychology, neuroscience, etc. So far, around 100 projects of clinical trials have been accomplished. Our achievements are well recognized by all sponsors.

We are highly responsible to our sponsors, to our employees, and to our society as well. www.proswell.com.cn

Quest Diagnostics

Quest Diagnostics is the largest clinical diagnostic testing company in the world with over 43,000 employees and $7 billion in annual revenues. The Clinical Trials business within Quest Diagnostics consists of over 600 employees providing unsurpassed laboratory testing and solutions to support global clinical trials.

Quest Diagnostics Clinical Trials provides laboratory solutions by harnessing the power of the entire Quest Diagnostics organization, including unsurpassed global central laboratory and biomarker services, diagnostics & esoteric testing, and research & development innovation, combined with one of the world’s largest clinical laboratory, a single global database, and unparalleled scientific and logistics expertise. www.questdiagnostics.com

Tigermed

Hangzhou Tigermed Consulting Co., Ltd is a leading Contract Research Organization (CRO) in China dedicated to providing regulatory affairs, Phase I-IV clinical trials, data management, biostatistics, medical translation and GCP training services for healthcare products. Since inception in 2004, Tigermed has been committed to accelerating your product development timeline while reducing R&D costs and risks, helping you to bring the miracles of your new product to market effectively. Headquartered in Hangzhou, Tigermed operates 4 subsidiaries, 35 offices in Mainland China and 1 offshore office in America. With more than 500 staff, Tigermed has set up global Standard Operating Procedures (SOPs) and successfully serviced more than 300 local and global clients in the conduct of hundreds of regulatory affairs, clinical trials, data management and biostatistics projects. For more information about Tigermed, please visit www.tigermed.net

Uppsala Monitoring Centre

The Uppsala Monitoring Centre provides focused products to the pharmaceutical industry, clinical research organizations, and governmental agencies. We serve all kinds of organizations that are involved in drug discovery, clinical research and drug safety – providing the tools and services to optimize development and life cycle management of drugs. "Tools and resources to enhance clinical trials and drug safety operations." www.umc-products.com

Venturepharm

Venturepharm Service CRO Group is the largest and publicly traded CRO in China, it's also a prestigious institution for traditional Chinese medicine research. VPS-CRO focuses on providing a wide range of services including clinical trials, pharmacodynamics, pharmacokinetics, pharmacology and toxicology studies, regulatory affairs and post-marketing of chemicals, biologicals, TCM, natural medicine and medical devices. Based on the technology and management advantages of Venturepharm (Canada) Pharmaceutical Company and its own professional team, as well as the Chinese market, policies and cultural characteristics, VPS-CRO quickly grew into the most influential and brand professional CRO company. www.venturepharm.com

ChinaBio®

Since its founding in January, 2007, ChinaBio® LLC has rapidly launched a number of initiatives accelerating the globalization of China’s life science industry. ChinaBio has helped China companies raise nearly $400 million and global life science companies identify over 400 licensing and acquisition opportunities in China. www.ChinaBioLLC.com

Modular R&D

Modular R&D is a specialty consulting and project management firm focused on drug and device development in China. Its services cover China healthcare and pharmaceutical market research, development strategy design, CRO selection and project management. Modular R&D consists of M.D. and Ph.D. consultants who have training and drug development experience both in China and in North America, with additional resources from industry leaders in the pharmaceutical industry, regulatory agencies, and contract research organizations. Modular R&D was created with the goal of building an effective and efficient system to help international companies integrate China into their global development plans. www.modularrandd.com